|
Volumn 26, Issue SUPPL. 1, 2005, Pages
|
Autologous haematopoietic stem cell transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CARMUSTINE;
CYCLOPHOSPHAMIDE;
CYTARABINE;
ETOPOSIDE;
MELPHALAN;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
THYMOCYTE ANTIBODY;
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION;
CLINICAL FEATURE;
CLINICAL TRIAL;
DISEASE COURSE;
DISEASE SEVERITY;
FOLLOW UP;
GENERAL CONDITION DETERIORATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INFECTION;
MULTIPLE SCLEROSIS;
NOTE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
QUALITY OF LIFE;
QUESTIONNAIRE;
STATISTICAL SIGNIFICANCE;
STEM CELL MOBILIZATION;
TREATMENT OUTCOME;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
MULTIPLE SCLEROSIS;
TRANSPLANTATION, AUTOLOGOUS;
|
EID: 18344376733
PISSN: 15901874
EISSN: None
Source Type: Journal
DOI: 10.1007/s10072-005-0394-9 Document Type: Note |
Times cited : (1)
|
References (3)
|